NCT01400334View on ClinicalTrials.gov

Prediction of ARrhythmic Events With Positron Emission Tomography

CompletedOBSERVATIONAL

Enrollment

257

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Ischemic CardiomyopathyHibernating MyocardiumNerve; Disorder, Sympathetic

Interventions

RADIATION

Positron Emission Tomography

Quantification of cardiac function using positron emission tomography and: a)11C-meta-hydroxyephedrine \[HED, 20 mCi (740 MBq)\] to quantify sympathetic nerve function, b) 13N-ammonia \[NH3, 20 mCi (740 MBq)\] for regional perfusion, and c) 18F-2-deoxyglucose \[FDG; 6.5 mCi (241 MBq)\] administered during a hyperinsulinemic-euglycemic clamp to assess viability.

Trial Locations (1)

14214

SUNYBuffalo, Buffalo

All Listed Sponsors

lead

State University of New York at Buffalo

OTHER

NCT01400334 - Prediction of ARrhythmic Events With Positron Emission Tomography | Biotech Hunter | Biotech Hunter